Publication | Closed Access
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
17
Citations
15
References
2016
Year
Hematological MalignancyMedicineHematologyMyeloid NeoplasiaMultiple Myeloma PatientsOncologyRadiation OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1